I found a June 1, 2016 article on the Children With Type 1 Diabetes website.
The current model of the Animas Vibe pump has integrated CGM using the Dexcom G4 sensors. Animas are looking to launch a pump using a brand new algorithm called HHM, which stands for Hypoglycemic-Hyperglycemic Minimizer. Essentially the new algorithm will put this pump one step closer to a closed loop system. The HHM technology will predict high and low glucose events, and can increase and decrease insulin automatically as required to minimize the risk of a hypo and to help keep blood glucose levels in range and from going to high. Amazing huh?
This description details a hybrid model. Here's more from the article:
It’s unclear at this stage if the next Animas pump will feature the full capabilities of the HHM [Hypoglycemic-Hyperglycemic Minimizer] technology or if the next pump will just be an improvement on the current Animas Vibe pump perhaps with the facility of Hypo Minimizer technology, prior to the launch of the full Hypo/Hyper Minimizer on a future pump. We’ll have to wait for an official announcement to find out what the full benefits will be of the next gen pump.
And it does mention that the product may be introduced in Sweden first but it hints at a 2016 introduction that appears to have slipped considering your comments. It also raises the issue of whether Animas will hold back the full introduction of the Hypo/Hyper Minimizer. Let's hope not!
There have been no dates announced so far for it’s launch in the UK, it looks like Swedish customers will be first to get their hands on this revolutionary kit, though some sources are expecting a new Animas Insulin [pump] at some point in 2016. Unfortunately I’ve no images or any further details at this time.
Here's more from a DiabetesMine column published February 1, 2016. The column covers updates on all the major players in the AP competition. It's worth clicking over to read but I sure wish there was more current news!
Animas: The company is presumably still working on their Hypo-Hyper Minimizer (HHM), although we haven't heard much -- nor seen any images -- since they last talked openly about this predictive system three years ago.
We reached out to Bridget Kimmel, Animas' senior manager of communications and public affairs, and were told:
“Animas’ partnership with JDRF has enabled development of best-in-class predictive algorithms for closed-loop insulin delivery. Three feasibility clinical studies have been completed and results have been published. The Animas team is driving this technology aggressively to pivotal clinical studies and remain committed to continued innovation that addresses the needs of all our patients."
While a new HHM research article was just published in the January 2016 issue of the Journal of Diabetes Science and Technology, and Animas is also scheduled for an oral presentation at ATTD in Italy this week, there's very little new information being circulated.
The study published involved 12 adults with type 1 diabetes using a closed-loop system with HHM in a clinical research center for approximately 24 hours, and the Minimizer definitely succeeded in "taking preemptive action to prevent hypoglycemia based on predicted changes in CGM glucose levels." Good!
Now show us a little more of what's in the works, Animas, if you want to stay in the closed-loop race.
Here's a summary update from diaTribe, dated May 27, 21016, on the status of many AP projects.